BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2002
View Archived Issues
Company Profile: Entomed
Read More
U.S. launch of Paremyd scheduled for March
Read More
Aricept associated with significant benefits in the treatment of vascular dementia
Read More
Forest receives approvable letter for Lexapro in major depressive disorder
Read More
Iressa under regulatory review in two major markets for NSCLC
Read More
Phase IIb results reported for OvaRex in metastatic ovarian cancer
Read More
Argenta Discovery and Lundbeck collaborate on CNS program
Read More
Synt:em collaborates with Baxter to develop monoclonal antibody mimetics
Read More
Novirio research consortium receives grant for antiflavivirus drug candidate development
Read More
Schering AG and Mologen to develop cell-based therapies
Read More
First Plantibodies candidate heads for clinical testing
Read More
Chemokine CCR1 receptor antagonist effective in mouse model of renal fibrosis
Read More
Preparation and use of new series of PDE5 inhibitors
Read More
Acylphenylurea derivatives effective as inhibitors of glycogen phosphorylase according to Aventis
Read More
Novel caspase inhibitors identified at Vertex
Read More
Pfizer team synthesizes selective adenosine A2A receptor agonists
Read More
Benzamide-containing compounds that act as ligands of thyroid hormone receptor beta
Read More
Preparation and use of purine derivatives with antiviral activity claimed
Read More
Rituximab + CHOP as a new drug combination for aggressive NHL
Read More
TKT's Fabry's disease enzyme replacement therapy available for use in E.U.
Read More
